Psilocybin: a psychedelic alternative to antidepressants?

Decades on from its widespread use as a recreational drug during the 1960s, research shows that psilocybin could be a credible treatment for symptoms of depression and other mental health disorders.
Pop art style illustration of brains

Shutterstock.com

In November 2022, the largest trial to date of the psychedelic drug, psilocybin, showed that — alongside psychological support — a single 25mg dose could improve the symptoms of treatment-resistant depression for up to 12 weeks.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated